We are live on
!
Find out more
BLAM
Bourne Lent Asset Management Portfolio holdings
AUM
$272M
1-Year Est. Return
30.95%
This Fund
S&P 500
This Quarter
Est. Return
+9.25%
1 Year Est. Return
+30.95%
3 Year Est. Return
+75.66%
5 Year Est. Return
+99.24%
10 Year Est. Return
+591.34%
AUM
$374M
AUM Growth
+$25.4M
(+7.3%)
Cap. Flow
-$1.61M
Cap. Flow
% of AUM
-0.43%
Top 10 Holdings %
Top 10 Hldgs %
74.45%
Holding
63
New
2
Increased
7
Reduced
10
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$942K |
| 2 |
NVTA
Invitae Corporation
NVTA
|
+$673K |
| 3 |
Consolidated Edison
ED
|
+$208K |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$201K |
| 5 |
AT&T
T
|
+$110K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.61M |
| 2 |
Idexx Laboratories
IDXX
|
+$451K |
| 3 |
IBM
IBM
|
+$204K |
| 4 |
Western Union
WU
|
+$202K |
| 5 |
Adobe
ADBE
|
+$163K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.58% |
| 2 | Healthcare | 30.43% |
| 3 | Communication Services | 12.13% |
| 4 | Consumer Discretionary | 5.68% |
| 5 | Industrials | 3.67% |
Similar funds
SC
SC
AGP
SFPG
TP
S
SS
LAM
Bourne Lent Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, Bourne Lent Asset Management held 63 positions worth $374M, up 7.3% from $348M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Bourne Lent Asset Management's Q4 2021 filing shows 2 new, 7 increased, 10 reduced and 2 closed positions. Its largest new stake was Consolidated Edison: 2,650 shares worth $226K. The largest sale was Bristol-Myers Squibb, an estimated $2.61M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 39% a quarter earlier, followed by Healthcare and Communication Services.
- Bourne Lent Asset Management's largest Q4 2021 buy was Consolidated Edison: 2,650 shares worth $226K.
- Bourne Lent Asset Management added most to Amgen in Q4 2021, an estimated $942K increase.
- Bourne Lent Asset Management's biggest Q4 2021 reduction was Bristol-Myers Squibb, cutting an estimated $2.61M.
- Bourne Lent Asset Management fully exited IBM in Q4 2021, selling an estimated $204K.
- Bourne Lent Asset Management's ten largest holdings make up 74% of its $374M portfolio in Q4 2021.
- Bourne Lent Asset Management opened 2 new positions and closed 2 in Q4 2021.
- Bourne Lent Asset Management's portfolio value rose 7.3% quarter-over-quarter to $374M.
Based on Bourne Lent Asset Management's 13F filing for Q4 2021, filed 20 Jan 2022.